Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review

Andrea C Lo; Caroline L Holloway; Kerry J Savage; Laurie H Sehn; Daniel F Worsley; Joseph M Connors; Tom Pickles

doi:10.1080/10428194.2022.2060505

Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review

Leuk Lymphoma. 2022 May;63(5):1242-1245. doi: 10.1080/10428194.2022.2060505. Epub 2022 May 5.

Authors

Andrea C Lo^{1

2

3}, Caroline L Holloway^{2

3

4}, Kerry J Savage^{3

5

6}, Laurie H Sehn^{3

5

6}, Daniel F Worsley⁷, Joseph M Connors^{3

5

6}, Tom Pickles^{1

2

3}

Affiliations

¹ Department of Radiation Oncology, British Columbia Cancer Vancouver, Vancouver, Canada.
² Department of Surgery, University of British Columbia (UBC), Vancouver, Canada.
³ BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada.
⁴ Department of Radiation Oncology, British Columbia Cancer Victoria, Victoria, Canada.
⁵ Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada.
⁶ Department of Medicine, University of British Columbia (UBC), Vancouver, Canada.
⁷ Department of Nuclear Medicine, Vancouver General Hospital, Vancouver, Canada.

PMID: 35514121
DOI: 10.1080/10428194.2022.2060505

No abstract available

Publication types

Letter

MeSH terms

Humans
Lymphoma, B-Cell, Marginal Zone* / diagnosis
Lymphoma, B-Cell, Marginal Zone* / radiotherapy
Orbital Neoplasms* / diagnosis
Orbital Neoplasms* / radiotherapy
Radioimmunotherapy
Retrospective Studies
Rituximab

Substances

Rituximab